Essex Investment Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,481
| Closed | -$52.8K | – | 363 |
|
|
2023
Q3 | $52.8K | Sell |
1,481
-13
| -0.9% | -$463 | 0.01% | 313 |
|
|
2023
Q2 | $68.9K | Hold |
1,494
| – | – | 0.01% | 315 |
|
|
2023
Q1 | $59.9K | Sell |
1,494
-18
| -1% | -$722 | 0.01% | 320 |
|
|
2022
Q4 | $70K | Hold |
1,512
| – | – | 0.01% | 313 |
|
|
2022
Q3 | $63K | Hold |
1,512
| – | – | 0.01% | 311 |
|
|
2022
Q2 | $90K | Sell |
1,512
-1,170
| -44% | -$69.6K | 0.01% | 315 |
|
|
2022
Q1 | $195K | Buy |
2,682
+348
| +15% | +$25.3K | 0.02% | 302 |
|
|
2021
Q4 | $196K | Sell |
2,334
-365
| -14% | -$30.7K | 0.02% | 310 |
|
|
2021
Q3 | $243K | Hold |
2,699
| – | – | 0.03% | 309 |
|
|
2021
Q2 | $257K | Sell |
2,699
-89
| -3% | -$8.48K | 0.03% | 317 |
|
|
2021
Q1 | $317K | Buy |
2,788
+395
| +17% | +$44.9K | 0.04% | 316 |
|
|
2020
Q4 | $331K | Hold |
2,393
| – | – | 0.04% | 317 |
|
|
2020
Q3 | $197K | Buy |
+2,393
| New | +$197K | 0.03% | 355 |
|
|
2016
Q2 | – | Sell |
-7,512
| Closed | -$476K | – | 337 |
|
|
2016
Q1 | $476K | Buy |
+7,512
| New | +$476K | 0.08% | 235 |
|